Ismail Simsek
About Ismail Simsek
Ismail Simsek serves as the Executive Medical Director at Alpine Immune Sciences, where he oversees clinical trials and engages with key opinion leaders in autoimmune diseases. He has extensive experience in rheumatology and clinical development, having previously held positions at Biosplice Therapeutics and the Turkish Armed Forces.
Current Role at Alpine Immune Sciences
Ismail Simsek serves as the Executive Medical Director at Alpine Immune Sciences, Inc., a position he has held since 2022. In this role, he leads the medical oversight and monitoring for Phase 1-3 clinical trials, focusing on conditions such as osteoarthritis and androgenetic alopecia. He has also been instrumental in mentoring junior Medical Directors, enhancing team capabilities and performance within the organization.
Previous Experience at Biosplice Therapeutics
Prior to his current role, Ismail Simsek worked at Biosplice Therapeutics as the Medical Director of Clinical Development from 2019 to 2022. During his three years in San Diego, California, he contributed to the development of clinical strategies and oversight for various therapeutic programs.
Education and Medical Training
Ismail Simsek completed his medical education at Gulhane Military Medical Academy in Ankara, Turkey, where he earned his Doctor of Medicine (M.D.) degree from 1987 to 1993. He furthered his training with an Internal Medicine Residency Program from 1996 to 2000 and completed a Rheumatology fellowship from 2003 to 2006. His academic background laid the foundation for his expertise in rheumatology and clinical development.
Research and Academic Contributions
Ismail Simsek has a history of involvement in academic and clinical research. He served as a Visiting Research Scholar at NYU Hospital for Joint Diseases from 2009 to 2010. Additionally, he held the position of Associate Professor of Medicine - Rheumatology at the Turkish Armed Forces, Gülhane Military Medical Academy from 2003 to 2014, where he contributed to medical education and research in rheumatology.
Clinical Leadership in Autoimmune Programs
In his current role, Ismail Simsek has established and led global key opinion leader engagement for lupus and autoimmune cytopenia programs. He has conducted several advisory boards and steering committee meetings to support these programs, demonstrating his commitment to enhancing the company's presence and advocacy development in the field of autoimmune diseases.